Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Glucocorticoids.php on line 2
Glucocorticoids
LE WE PMID CA
Glucocorticoids1024Glukokortikoide

11 beta HSD1

11 beta hydroxysteroid dehydrogenase

4F2 LAT

ACTH

ADH AVP Vasopressin

Adiponectin

AMP activated protein kinase

Antiinflammatory compounds

AP1

Apoptosis

AQP2

ASCT2

ASIC1

beta oxidation

Calbindin D28k

Calbindin D9k

Calcium (Hypercalciuria)

Calcium (Physiology Intestines)

Calcium (Physiology renal)

Cardiovascular risk

Cell volume

CFTR ABCC7

Circadian clock

CLCN2 ClC2

Cryptochrome

EAAT1

EAAT2

EAAT3

EAAT4

EAAT5

Endocannabinoid

Fatty acids (Biosynthesis)

Fatty acids (oxidation)

Ghrelin

GILZ

Glucocorticoids

Gluconeogenesis

GluR6

GLUT1

Glycogen

Glycolysis

GSK3

Heart failure (BASKET)

Immunopsychiatry

Inflammation resolution

Insulin (BASKET)

Ion channel (BASKET)

Ion channel (Sodium ENaC)

KCNQ1

KCNQ2

KCNQ3

KCNQ4

KCNQ5

Kidney (Anatomy)

Kidney (Principal cells)

Kir1 1 ROMK

Kv1 1

Kv1 2

Kv1 3

Kv1 4

Kv1 5

Leptin

Levodopa

Lipocortin

Liver (Cirrhosis)

Magnesium (Hypomagnesiemia)

Metabolic syndrome

Metformin

MIF

Mineralocorticoid resistance

Mineralocorticoids

Mitochondria (BASKET)

mTORC2

NaDC

NaPiIIb

NCC

Nedd4 2

Neonatology

NFKB

NHE3

NKCC2

Nutrition (Neuroendocrinology)

Osteoporosis

Oxytocin

Parkinson s disease

PepT2

Period gene

Phosphomannomutase 2 PMM2

PMCA1b

Pregnancy (Diseases)

Receptor (Glucocorticoid)

SCN5A

Sepsis

SGK1

SLC2A4 GLUT4

SLC5A1 SGLT1

SMIT

SN1

Sodium (Hyponatriemia)

SRG3

Statistics and trial design

Stress (Neurophysiology)

Suprachiasmatic nuclei

Tacrolimus FK506

Thiazolidinediones

Thymus (BASKET)

Thyroid (Hypothyreosis)

TRPM6

TRPV5

TRPV6

VSOAC

2009  
1
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.
[19239478] Br J Pharmacol 156(5): 689-712 (2009)
2006  
2
How corticosteroids control inflammation: Quintiles Prize Lecture 2005.
[16604091] Br J Pharmacol 148(3): 245-54 (2006)
1988  
3
Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids.
[2974738] Br J Pharmacol 94(4): 987-1015 (1988)
2001  
4
Molecular mechanisms of corticosteroids in allergic diseases.
[11576070] Allergy 56(10): 928-36 (2001)
1998  
5
Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
[9792333] Mediators Inflamm 7(4): 229-37 (1998)
1998  
6
Topical glucocorticoids and the skin--mechanisms of action: an update.
[9705606] Mediators Inflamm 7(3): 183-93 (1998)
2008  
7
The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.
[18664528] J Leukoc Biol 84(4): 924-31 (2008)
2002  
8
Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor.
[11781376] J Leukoc Biol 71(1): 9-15 (2002)
1996  
9
Regulation of cytokine and cytokine receptor expression by glucocorticoids.
[8929546] J Leukoc Biol 60(5): 563-72 (1996)
2009  
10
Innovative combination strategy to enhance effect and diminish adverse effects of glucocorticoids: another promise?
[19291268] Arthritis Res Ther 11(1): 105 (2009)
2006  
11
Initial response to glucocorticoids.
[16342251] Cancer 106(2): 383-7 (2006)
2002  
12
Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
[12060604] Clin Cancer Res 8(6): 1681-94 (2002)
1998  
13
Syndromes of glucocorticoid and mineralocorticoid resistance.
[9724063] Eur J Endocrinol 139(2): 127-38 (1998)
2008  
14
Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.
[18319312] J Clin Endocrinol Metab 93(5): 1563-72 (2008)
2003  
15
The molecular and cellular basis of corticosteroid resistance.
[14656201] J Endocrinol 179(3): 301-10 (2003)
2001  
16
Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes.
[11375113] J Endocrinol 169(3): 437-45 (2001)
1998  
17
Systemic corticosteroid therapy--side effects and their management.
[9797677] Br J Ophthalmol 82(6): 704-8 (1998)
2009  
18
Central actions of glucocorticoids in the control of body fluid homeostasis: review.
[19219298] Braz J Med Biol Res 42(1): 61-7 (2009)
1992  
19
Four decades of glucocorticosteroid immunosuppression.
[1521206] CMAJ 147(5): 613-4 (1992)
2004  
20
The local side effects of inhaled corticosteroids: current understanding and review of the literature.
[15249465] Chest 126(1): 213-9 (2004)
2003  
21
Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology.
[14665517] Chest 124(6): 2329-40 (2003)
2004  
22
Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.
[15243581] Cell Death Differ 11 Suppl 1(-): S45-55 (2004)
2009  
23
11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.
[19837912] J Clin Endocrinol Metab 94(12): 4645-54 (2009)
2007  
24
Glucocorticoids and cardiovascular disease.
[17984234] Eur J Endocrinol 157(5): 545-59 (2007)
2004  
25
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
[15466942] Endocr Rev 25(5): 831-66 (2004)
2010  
26
Significance of SGK1 in the regulation of neuronal function.
[20530112] J Physiol 588(Pt 18): 3349-54 (2010)
2007  
27
Gastroprotective role of glucocorticoid hormones.
[17598953] J Pharmacol Sci 104(3): 195-201 (2007)
2006  
28
Glucocorticoids in T cell apoptosis and function.
[16314919] Cell Mol Life Sci 63(1): 60-72 (2006)
2009  
29
Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action.
[19567371] FASEB J 23(11): 3649-58 (2009)
2009  
30
Conference summary and conclusions. A comprehensive approach to predicting and managing mood effects of glucocorticoids.
[19906243] Ann N Y Acad Sci 1179(-): 229-33 (2009)
2009  
31
Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.
[19906238] Ann N Y Acad Sci 1179(-): 153-66 (2009)
2009  
32
Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.
[19906229] Ann N Y Acad Sci 1179(-): 1-18 (2009)
2006  
33
Corticosteroids in the management of early and established rheumatoid disease.
[16880186] Rheumatology (Oxford) 45(9): 1058-61 (2006)
2003  
34
Corticosteroids: the "terminator" of all untreatable serious pulmonary illness.
[14668251] Am J Respir Crit Care Med 168(12): 1409-10 (2003)
2010  
35
The use of topical corticoids in oral pathology.
[20526258] Med Oral Patol Oral Cir Bucal 15(6): e827-31 (2010)
2007  
36
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
[18209880] Arq Bras Endocrinol Metabol 51(8): 1404-12 (2007)
2006  
37
2010  
38
Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.
[20626892] Crit Care 14(4): R134 (2010)
2010  
39
Corticosteroids for sepsis: registry versus Cochrane systematic review!
[20727225] Crit Care 14(4): 185 (2010)
2010  
40
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry.
[20525247] Crit Care 14(3): R102 (2010)
2007  
41
Glucocorticoid therapy: minimizing side effects.
[18000630] J Pediatr (Rio J) 83(5 Suppl): S163-77 (2007)
2008  
42
Withdrawal from glucocorticosteroid therapy: clinical practice recommendations.
[18535733] J Pediatr (Rio J) 84(3): 192-202 (2008)
2011  
43
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.
[20398732] Mol Cell Endocrinol 335(1): 2-13 (2011)
2009  
44
Molecular mechanisms regulating glucocorticoid sensitivity and resistance.
[19000736] Mol Cell Endocrinol 300(1-2): 7-16 (2009)
2007  
45
Postnatal corticosteroids for chronic lung disease (CLD).
[17684306] Indian Pediatr 44(7): 531-9 (2007)
2010  
46
Levodopa in the treatment of Parkinson's disease: an old drug still going strong.
[20852670] Clin Interv Aging 5(-): 229-38 (2010)
2010  
47
Glucocorticoid-induced osteoporosis in rheumatic diseases.
[21243296] Clinics (Sao Paulo) 65(11): 1197-205 (2010)
2008  
48
Vasopressin and aquaporin 2 in clinical disorders of water homeostasis.
[18519089] Semin Nephrol 28(3): 289-96 (2008)
2011  
49
Rapid non-genomic effects of corticosteroids and their role in the central stress response.
[21357682] J Endocrinol 209(2): 153-67 (2011)
2011  
50
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
[21602312] J Endocrinol 211(1): 17-25 (2011)
2003  
51
Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
[12844332] J Endocrinol 178(1): 19-27 (2003)
2007  
52
Circadian clocks: regulators of endocrine and metabolic rhythms.
[17951531] J Endocrinol 195(2): 187-98 (2007)
2008  
53
Tissue-specific glucocorticoid action: a family affair.
[18805703] Trends Endocrinol Metab 19(9): 331-9 (2008)
2007  
54
Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6.
[16901990] Am J Physiol Gastrointest Liver Physiol 292(1): G92-7 (2007)
2009  
55
The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder.
[19490920] Life Sci 85(3-4): 146-52 (2009)
2004  
56
Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia.
[14978156] J Am Soc Nephrol 15(3): 549-57 (2004)
2010  
57
Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney.
[19920212] Physiol Genomics 40(3): 158-66 (2010)
2008  
58
Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.
[18295199] Eur J Pharmacol 583(2-3): 322-39 (2008)
2007  
59
An inflammatory review of glucocorticoid actions in the CNS.
[17194565] Brain Behav Immun 21(3): 259-72 (2007)
2010  
60
Adverse effects of extra-articular corticosteroid injections: a systematic review.
[20836867] BMC Musculoskelet Disord 11(-): 206 (2010)
2011  
61
Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis.
[20628753] Eur Arch Otorhinolaryngol 268(2): 247-53 (2011)
2010  
62
Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.
[20649902] Eur J Clin Invest 40(10): 932-42 (2010)
2011  
63
Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.
[21949634] Integr Blood Press Control 4(-): 7-16 (2011)
2003  
64
Steroid induced psychosis in an asthmatic child: case report & 10 year literature review.
[19030155] Can Child Adolesc Psychiatr Rev 12(4): 117-8 (2003)
2011  
65
A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs.
[21941526] PPAR Res 2011(-): 742785 (2011)
2010  
66
Prevention and treatment of systemic glucocorticoid side effects.
[20465658] Int J Dermatol 49(3): 239-48 (2010)
2011  
67
11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.
[21144857] Front Neuroendocrinol 32(3): 265-86 (2011)
2010  
68
Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids.
[19903506] Prog Neuropsychopharmacol Biol Psychiatry 34(5): 791-7 (2010)
2010  
69
New understanding of glucocorticoid action in bone cells.
[20797313] BMB Rep 43(8): 524-9 (2010)
2007  
70
The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity.
[17389748] Mol Endocrinol 21(6): 1267-80 (2007)
2009  
71
Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.
[19095768] Mol Endocrinol 23(3): 281-91 (2009)
2002  
72
Rescuing developing thymocytes from death by neglect.
[16248964] J Biochem Mol Biol 35(1): 7-18 (2002)
2010  
73
AMPK as a mediator of hormonal signalling.
[19625456] J Mol Endocrinol 44(2): 87-97 (2010)
2011  
74
Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids.
[21149445] J Biol Chem 286(5): 3177-84 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Glucocorticoids.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Glucocorticoids.php on line 92